$CTIC Company News

New Post Public Reply Private Reply Replies (0) Message Board

May 19, 2014 at 10:29 AM

$CTIC Company News

Insider filings one way to track tricky micro-cap biotechs

12:14 p.m. Oct. 24, 2012
- blogs.marketwatch.com

Friday’s biggest gaining and declining stocks
4:27 p.m. Oct. 5, 2012
- Greg Morcroft

Cell Therapeutics down 21% in premarket
7:15 a.m. Oct. 5, 2012
- Steve Gelsi

Tuesday’s biggest gaining and declining stocks
4:53 p.m. Oct. 2, 2012
- MarketWatch

Cell Therapeutics up 21% in premarket
8:38 a.m. Oct. 2, 2012
- Steve Gelsi

CTIC gets orphan drug status for brain cancer drug
7:37 a.m. Oct. 2, 2012
- MarketWatch.com

Cell Therapeutics: progress with lymphoma Drug
6:59 a.m. Sept. 24, 2012
- MarketWatch.com

Tuesday’s top gaining and declining stocks
4:57 p.m. Sept. 11, 2012
- MarketWatch

Cell Therapeutics soars 24% on EU drug launch
10:12 a.m. Sept. 11, 2012
- Val Brickates Kennedy

Tuesday’s biggest gaining and declining stocks
5:01 p.m. Sept. 4, 2012
- Greg Morcroft

Updates, advisories and surprises
5:01 p.m. July 31, 2012
- MarketWatch

Cell Therapeutics announces stock placement
11:45 a.m. July 31, 2012
- Val Brickates Kennedy

Friday’s biggest gaining and declining stocks
5:21 p.m. Feb. 17, 2012
- Kate Gibson

Monday’s biggest gaining and declining stocks
5:49 p.m. Jan. 30, 2012
- Kate Gibson

Cell Therapeutics pulls application; shares slump
2:25 p.m. Jan. 30, 2012
- MarketWatch.com

Stocks to watch Monday: Blue Coat, Cooper
5:35 p.m. Dec. 9, 2011
- William Spain

Friday’s biggest gaining & declining stocks
5:35 p.m. Dec. 9, 2011
- Kate Gibson

Thursday’s biggest gaining & declining stocks
4:59 p.m. June 30, 2011
- Kate Gibson

Cell Therapeutics tumbles over offerings
9:09 a.m. June 30, 2011
- MarketWatch.com

Biotech Stock Mailbag: Sarepta, F-R Rule Stock Predictions, Merrimack

6:00 a.m. May 9, 2014
- TheStreet.com

Cell Therapeutics: Enticing To All, Convincing To None

9:10 a.m. May 7, 2014
- Seeking Alpha

Cell Therapeutics CEO Discusses Q1 2014 Results - Earnings Call Transcript

10:52 p.m. April 29, 2014
- Seeking Alpha

10-Q: CELL THERAPEUTICS INC
5:10 p.m. April 29, 2014
- Edgar Online - (EDG = 10Q, 10K)

Furiex Pharmaceuticals (FURX) Surges: Stock Moves 28.6% Higher - Tale of the Tape

9:21 a.m. April 29, 2014
- Zacks.com

Pacira Pharmaceuticals (PCRX) Soars: Stock Adds 11.4% in Session - Tale of the Tape

9:21 a.m. April 10, 2014
- Zacks.com

Insider Trading Alert - CTIC, KR And IBKR Traded By Insiders

10:45 a.m. March 31, 2014
- TheStreet.com

Zacks Rank #1 Additions for Friday - Tale of the Tape

9:30 a.m. March 28, 2014
- Zacks.com

First Week Of CTIC May 17th Options Trading

12:54 p.m. March 26, 2014
- TheStreet.com

Cell Therapeutics: 5 Different Insiders Have Sold Shares This Month

10:39 a.m. March 24, 2014
- Seeking Alpha

Weekly CEO Sells Highlight: Groupon Inc., Cell Therapeutics Inc. ...

10:12 a.m. March 24, 2014
- GuruFocus.com

Geron: FDA Suspends Key Myelofibrosis Drug Due to Liver Safety Concerns

9:57 a.m. March 12, 2014
- TheStreet.com

Insider Trading Alert - CTIC, TCBI And FCS Traded By Insiders

1:16 p.m. March 10, 2014
- TheStreet.com

Is It Too Late to Buy the Rally in Small Caps?

12:00 a.m. March 7, 2014
- InvestorPlace.com

Cell Therapeutics' CEO Discusses Q4 2013 Results - Earnings Call Transcript

9:21 p.m. March 4, 2014
- Seeking Alpha

10-K: CELL THERAPEUTICS INC
5:32 p.m. March 4, 2014
- Edgar Online - (EDG = 10Q, 10K)

Cell Therapeutics Q4 revenue soars due to Baxter license payment

4:49 p.m. March 4, 2014
- Seeking Alpha

Cell Therapeutics' Pixuvri gets final NICE recommendation

9:47 a.m. Feb. 27, 2014
- Seeking Alpha

Interesting CTIC Put And Call Options For April 19th

11:01 a.m. Feb. 26, 2014
- TheStreet.com

NewLink's Pancreatic Cancer Vaccine and the Feuerstein-Ratain Rule

7:33 a.m. Feb. 26, 2014
- TheStreet.com

Technical Coverage on Biotech Stocks -- Research on Celgene, Cell Therapeutics, Geron, and BioMarin Pharma
9:15 a.m. May 6, 2014
- PR Newswire - PRF

Cell Therapeutics Reports First Quarter 2014 Financial Results
4:01 p.m. April 29, 2014
- PR Newswire - PRF

PIXUVRI® Launched In UK For Adult Patients With Multiply Relapsed Or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
1:30 a.m. April 29, 2014
- PR Newswire - PRF

Cell Therapeutics to Report First Quarter 2014 Financial Results on April 29, 2014
1:30 a.m. April 22, 2014
- PR Newswire - PRF

Insider Trading Research -- Alerts for Ariad Pharmaceuticals, Cell Therapeutics, Staples, Sirius XM, Facebook, and Bank of America
8:55 a.m. March 25, 2014
- PR Newswire - PRF

Initiation of Clinical Trials, Completed Acquisitions, Financial Results, and Earnings Release Schedules - Analyst Notes on Cell Therapeutics, Intrexon, Chimerix, Receptos, and Revance Therapeutics
8:00 a.m. March 18, 2014
- PR Newswire - PRF

Investor-Edge.com Most Active Equities Watch List: Cell Therapeutics, Yandex, Himax Technologies, and CytRx
8:54 a.m. March 14, 2014
- PR Newswire - PRF

Cell Therapeutics to Present at the 26th Annual ROTH Conference
2:30 a.m. March 5, 2014
- PR Newswire - PRF

Cell Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results
5:00 p.m. March 4, 2014
- PR Newswire - PRF

CTI Opens Enrollment for PERSIST-2 Phase 3 Trial of Pacritinib for Patients with Myelofibrosis Who Have Low Platelet Counts
2:30 a.m. March 3, 2014
- PR Newswire - PRF

NICE Publishes Final Guidance on PIXUVRI® (pixantrone)
2:30 a.m. Feb. 27, 2014
- PR Newswire - PRF

Cell Therapeutics to Report Fourth Quarter and Full Year 2013 Financial Results on March 4, 2014
2:30 a.m. Feb. 25, 2014
- PR Newswire - PRF

Hercules Offshore Losses Decrease from $121 million to $27 million
10:17 a.m. Feb. 24, 2014
- ACCESSWIRE

Glu Mobile and Siri XM Stock Volume Soars on Fourth-Quarter Results: Glu Mobile Inc.'s (NASDAQ: GLUU), Sirius XM Holdings Inc. (NASDAQ: SIRI), Zynga Inc. (NASDAQ:ZNGA, Cell Therapeutics Inc. (NASDAQ:CTIC)
11:12 a.m. Feb. 11, 2014
- ACCESSWIRE

Cell Therapeutics Appoints Karen Ignagni to Board of Directors
2:30 a.m. Feb. 3, 2014
- PR Newswire - PRF

CTI Announces United Kingdom National Cancer Research Institute AML Cooperative Group Phase 2 Trial Evaluating Pacritinib for Patients with Relapsed FLT3 Positive Acute Myeloid Leukemia
2:30 a.m. Jan. 30, 2014
- PR Newswire - PRF

Cell Therapeutics Announces GOG Completes Patient Enrollment in GOG-0212 Phase 3 Clinical Trial of Paclitaxel Poliglumex (Opaxio™) as Maintenance Therapy in Ovarian Cancer
2:30 a.m. Jan. 28, 2014
- PR Newswire - PRF

Most Active Stocks Range from Online Game Maker to Biopharmaceuticals: Zynga Inc. (NASDAQ:ZNGA), Dynavax Technologies Corp. (NASDAQ: DVAX), Cell Therapeutics Inc. (NASDAQ:CTIC)
8:23 a.m. Jan. 20, 2014
- ACCESSWIRE

Morning Buzzers: Cell Therapeutics Inc, Stratasys, Galena Biopharma, Cliffs Natural Resources
11:52 a.m. Jan. 14, 2014
- ACCESSWIRE

Cell Therapeutics Announces 2014 Outlook and Recent Drug Portfolio Progress
2:30 a.m. Jan. 14, 2014
- PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innventure Faces Class Action: SEC Whistleblowers Invited

When Fiction Meets the Stock Market Here's a wild twist in the investment world: Innventure, Inc. (NASDAQ: INV) found itself in hot water, as its stock took a nosedive, plunging 55% on August 14, 2026. Imagine seeing your investments crumble just like that. What lit this fire? The decision to yank their DarkNX project from 2026 expectations and hit pause on their revenue...

Beazer Homes Sale Scrutinized for Shareholder Impact

Spotlight on Beazer Homes' Proposed Sale Here's a real head-scratcher for folks in the stock trenches: Beazer Homes USA, Inc. (NYSE: BZH) finds itself under the microscope with Halper Sadeh LLC stirring the pot. You can't make this up—just another day in the world of investor rights and looming litigation. Questions Arise Over Shareholder Gains Halper Sadeh LLC, that...

ASCEND® Cladding Unveils New Profiles & Texture Variety

New Options for Creative Home Exteriors Amid today's housing market rollercoaster, a sprinkle of bold innovation in building materials can make a statement—and that's precisely what Associated Materials Innovations (AMI) is banking on with their latest beef-up in the ASCEND® Composite Cladding lineup. Introduced out of Cuyahoga Falls on Sept. 8, 2026, this expansion...

Dentsply Sirona Faces Insider Troubles: An Investor Call

Are Dentsply Sirona Insiders on Thin Ice? The stock market's a tumultuous sea, and right now, it seems like some of those at the helm of Dentsply Sirona Inc. might be rocking the boat a bit too much. Let me tell you, navigating these corporate storms isn't for the faint-hearted. The latest noise coming from Halper Sadeh LLC suggests that some directors and officers over...

1M+ California Homes Face Extreme Wildfire Risk Revealed

Wildfire Risk in California: A Growing Alarm If there's one thing that's become a bitter truth over the years, it's that California and wildfires are inseparably linked, like mayo on a greasy diner BLT—except way worse for the gut. The latest round of data from Guidewire HazardHub is practically sounding the alarm bells louder than ever. Over a million homes in...

Interventional Ophthalmology: Early Eye Care Strategies Evolve

Proactive Eye Care: The New Frontier Today's eye care landscape is all about catching things early, folks. Long gone are the days of waiting for eyesight to deteriorate before rushing to the nearest eye doc. In Racine, interventional ophthalmology is shifting gears towards preventive care—looking ahead to stop eye diseases in their tracks before they muck up a person's...

Jollibee and DreamWorks Unite for Cultural Celebration

Jollibee Partners with DreamWorks Animation Never thought I’d see the day: Jollibee, that familiar face of fast food, teaming up with the creative juggernaut DreamWorks Animation. They’re calling it a celebration of friendship and Filipino culture, wrapped up neatly in the context of a flick called Forgotten Island. Set to sizzle in theaters on September 25, 2026,...

Big Wins at Americas Cardroom's $15M Venom Series

High Stakes and Huge Paydays: The Venom Breakdown Alright, folks, here's a tale of how the cards fell in one of the most electrifying poker standoffs at Americas Cardroom. With prize pools clocking in at a staggering $15.095 million, the Dual Mystery Bounty Venoms really stacked the chips high. From the gritty, bustling halls of the internet to the proverbial green-felt...

DNOW Faces Class Action: Proxy Missteps Under Fire

DNOW's Rough Patch: Investors, Beware Here's a tangled mess for you: DNOW Inc., a name that should've been cruising post-merger, now finds itself smack in the middle of a class action lawsuit. Blame it on some botched acquisition moves with MRC Global Inc. The suits claim DNOW's management may have played fast and loose with the truth during their big merger spiel. When...

Nashville Benefit Concert Supports Animal Rescue Mission

Country Tunes and Compassion Unite for Rescue Efforts There's something electric about a community banding together, especially when it's through the warmth of country music and the noble mission of animal rescue. Animal Rescue Corps (ARC), meeting ground for art and heart, is turning the Nashville Palace into a sanctuary not just for music, but for hope. They've got...